The global market for Biomarker Discovery Platform was valued at US$ 554 million in the year 2024 and is projected to reach a revised size of US$ 768 million by 2031, growing at a CAGR of 4.8% during the forecast period.
A biomarker discovery platform is an integrated system of technologies, methodologies, and computational tools used to identify, validate, and analyze biological markers鈥攎olecules that indicate normal or pathological processes, or responses to therapeutic interventions. These platforms typically combine high-throughput techniques such as genomics, proteomics, metabolomics, and transcriptomics with advanced data analytics and machine learning to uncover potential biomarkers from complex biological samples. Biomarker discovery platforms are essential in the development of diagnostic tools, targeted therapies, and personalized medicine approaches, as they enable researchers and clinicians to detect disease early, monitor progression, and predict treatment outcomes. They are widely used in pharmaceutical and biotechnology research, clinical trials, and translational medicine to bridge the gap between laboratory findings and clinical applications.
North American market for Biomarker Discovery Platform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Biomarker Discovery Platform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Biomarker Discovery Platform in Academic and Research Institutions is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Biomarker Discovery Platform include Synexa Life Sciences, Exosome Diagnostics, ALS, Sapient Bioanalytics, Oncimmune Holdings, Evotec, Wuxi Apptec, Baker Heart and Diabetes Institute, BostonGene, Olink, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biomarker Discovery Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomarker Discovery Platform.
The Biomarker Discovery Platform market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biomarker Discovery Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biomarker Discovery Platform companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Synexa Life Sciences
Exosome Diagnostics
ALS
Sapient Bioanalytics
Oncimmune Holdings
Evotec
Wuxi Apptec
Baker Heart and Diabetes Institute
BostonGene
Olink
Proteomics International
Excelra
Oncimmune
Broad Clinical Labs
Genialis
Biognosys
Scailyte
Sapient
IQVIA Laboratories
Shanghai InnoStar Bio-tech
Fapon Biopharma
Cobio
Segment by Type
Web-based
Cloud-based
Segment by Application
Academic and Research Institutions
Pharmaceutical and Biotech Companies
Government and Regulatory Agencies
Hospitals and Clinical Laboratories
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biomarker Discovery Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biomarker Discovery Platform Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Web-based
1.2.3 Cloud-based
1.3 Market by Application
1.3.1 Global Biomarker Discovery Platform Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Academic and Research Institutions
1.3.3 Pharmaceutical and Biotech Companies
1.3.4 Government and Regulatory Agencies
1.3.5 Hospitals and Clinical Laboratories
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biomarker Discovery Platform Market Perspective (2020-2031)
2.2 Global Biomarker Discovery Platform Growth Trends by Region
2.2.1 Global Biomarker Discovery Platform Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biomarker Discovery Platform Historic Market Size by Region (2020-2025)
2.2.3 Biomarker Discovery Platform Forecasted Market Size by Region (2026-2031)
2.3 Biomarker Discovery Platform Market Dynamics
2.3.1 Biomarker Discovery Platform Industry Trends
2.3.2 Biomarker Discovery Platform Market Drivers
2.3.3 Biomarker Discovery Platform Market Challenges
2.3.4 Biomarker Discovery Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biomarker Discovery Platform Players by Revenue
3.1.1 Global Top Biomarker Discovery Platform Players by Revenue (2020-2025)
3.1.2 Global Biomarker Discovery Platform Revenue Market Share by Players (2020-2025)
3.2 Global Top Biomarker Discovery Platform Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biomarker Discovery Platform Revenue
3.4 Global Biomarker Discovery Platform Market Concentration Ratio
3.4.1 Global Biomarker Discovery Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biomarker Discovery Platform Revenue in 2024
3.5 Global Key Players of Biomarker Discovery Platform Head office and Area Served
3.6 Global Key Players of Biomarker Discovery Platform, Product and Application
3.7 Global Key Players of Biomarker Discovery Platform, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biomarker Discovery Platform Breakdown Data by Type
4.1 Global Biomarker Discovery Platform Historic Market Size by Type (2020-2025)
4.2 Global Biomarker Discovery Platform Forecasted Market Size by Type (2026-2031)
5 Biomarker Discovery Platform Breakdown Data by Application
5.1 Global Biomarker Discovery Platform Historic Market Size by Application (2020-2025)
5.2 Global Biomarker Discovery Platform Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biomarker Discovery Platform Market Size (2020-2031)
6.2 North America Biomarker Discovery Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biomarker Discovery Platform Market Size by Country (2020-2025)
6.4 North America Biomarker Discovery Platform Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biomarker Discovery Platform Market Size (2020-2031)
7.2 Europe Biomarker Discovery Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biomarker Discovery Platform Market Size by Country (2020-2025)
7.4 Europe Biomarker Discovery Platform Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biomarker Discovery Platform Market Size (2020-2031)
8.2 Asia-Pacific Biomarker Discovery Platform Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biomarker Discovery Platform Market Size by Region (2020-2025)
8.4 Asia-Pacific Biomarker Discovery Platform Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biomarker Discovery Platform Market Size (2020-2031)
9.2 Latin America Biomarker Discovery Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biomarker Discovery Platform Market Size by Country (2020-2025)
9.4 Latin America Biomarker Discovery Platform Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biomarker Discovery Platform Market Size (2020-2031)
10.2 Middle East & Africa Biomarker Discovery Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biomarker Discovery Platform Market Size by Country (2020-2025)
10.4 Middle East & Africa Biomarker Discovery Platform Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Synexa Life Sciences
11.1.1 Synexa Life Sciences Company Details
11.1.2 Synexa Life Sciences Business Overview
11.1.3 Synexa Life Sciences Biomarker Discovery Platform Introduction
11.1.4 Synexa Life Sciences Revenue in Biomarker Discovery Platform Business (2020-2025)
11.1.5 Synexa Life Sciences Recent Development
11.2 Exosome Diagnostics
11.2.1 Exosome Diagnostics Company Details
11.2.2 Exosome Diagnostics Business Overview
11.2.3 Exosome Diagnostics Biomarker Discovery Platform Introduction
11.2.4 Exosome Diagnostics Revenue in Biomarker Discovery Platform Business (2020-2025)
11.2.5 Exosome Diagnostics Recent Development
11.3 ALS
11.3.1 ALS Company Details
11.3.2 ALS Business Overview
11.3.3 ALS Biomarker Discovery Platform Introduction
11.3.4 ALS Revenue in Biomarker Discovery Platform Business (2020-2025)
11.3.5 ALS Recent Development
11.4 Sapient Bioanalytics
11.4.1 Sapient Bioanalytics Company Details
11.4.2 Sapient Bioanalytics Business Overview
11.4.3 Sapient Bioanalytics Biomarker Discovery Platform Introduction
11.4.4 Sapient Bioanalytics Revenue in Biomarker Discovery Platform Business (2020-2025)
11.4.5 Sapient Bioanalytics Recent Development
11.5 Oncimmune Holdings
11.5.1 Oncimmune Holdings Company Details
11.5.2 Oncimmune Holdings Business Overview
11.5.3 Oncimmune Holdings Biomarker Discovery Platform Introduction
11.5.4 Oncimmune Holdings Revenue in Biomarker Discovery Platform Business (2020-2025)
11.5.5 Oncimmune Holdings Recent Development
11.6 Evotec
11.6.1 Evotec Company Details
11.6.2 Evotec Business Overview
11.6.3 Evotec Biomarker Discovery Platform Introduction
11.6.4 Evotec Revenue in Biomarker Discovery Platform Business (2020-2025)
11.6.5 Evotec Recent Development
11.7 Wuxi Apptec
11.7.1 Wuxi Apptec Company Details
11.7.2 Wuxi Apptec Business Overview
11.7.3 Wuxi Apptec Biomarker Discovery Platform Introduction
11.7.4 Wuxi Apptec Revenue in Biomarker Discovery Platform Business (2020-2025)
11.7.5 Wuxi Apptec Recent Development
11.8 Baker Heart and Diabetes Institute
11.8.1 Baker Heart and Diabetes Institute Company Details
11.8.2 Baker Heart and Diabetes Institute Business Overview
11.8.3 Baker Heart and Diabetes Institute Biomarker Discovery Platform Introduction
11.8.4 Baker Heart and Diabetes Institute Revenue in Biomarker Discovery Platform Business (2020-2025)
11.8.5 Baker Heart and Diabetes Institute Recent Development
11.9 BostonGene
11.9.1 BostonGene Company Details
11.9.2 BostonGene Business Overview
11.9.3 BostonGene Biomarker Discovery Platform Introduction
11.9.4 BostonGene Revenue in Biomarker Discovery Platform Business (2020-2025)
11.9.5 BostonGene Recent Development
11.10 Olink
11.10.1 Olink Company Details
11.10.2 Olink Business Overview
11.10.3 Olink Biomarker Discovery Platform Introduction
11.10.4 Olink Revenue in Biomarker Discovery Platform Business (2020-2025)
11.10.5 Olink Recent Development
11.11 Proteomics International
11.11.1 Proteomics International Company Details
11.11.2 Proteomics International Business Overview
11.11.3 Proteomics International Biomarker Discovery Platform Introduction
11.11.4 Proteomics International Revenue in Biomarker Discovery Platform Business (2020-2025)
11.11.5 Proteomics International Recent Development
11.12 Excelra
11.12.1 Excelra Company Details
11.12.2 Excelra Business Overview
11.12.3 Excelra Biomarker Discovery Platform Introduction
11.12.4 Excelra Revenue in Biomarker Discovery Platform Business (2020-2025)
11.12.5 Excelra Recent Development
11.13 Oncimmune
11.13.1 Oncimmune Company Details
11.13.2 Oncimmune Business Overview
11.13.3 Oncimmune Biomarker Discovery Platform Introduction
11.13.4 Oncimmune Revenue in Biomarker Discovery Platform Business (2020-2025)
11.13.5 Oncimmune Recent Development
11.14 Broad Clinical Labs
11.14.1 Broad Clinical Labs Company Details
11.14.2 Broad Clinical Labs Business Overview
11.14.3 Broad Clinical Labs Biomarker Discovery Platform Introduction
11.14.4 Broad Clinical Labs Revenue in Biomarker Discovery Platform Business (2020-2025)
11.14.5 Broad Clinical Labs Recent Development
11.15 Genialis
11.15.1 Genialis Company Details
11.15.2 Genialis Business Overview
11.15.3 Genialis Biomarker Discovery Platform Introduction
11.15.4 Genialis Revenue in Biomarker Discovery Platform Business (2020-2025)
11.15.5 Genialis Recent Development
11.16 Biognosys
11.16.1 Biognosys Company Details
11.16.2 Biognosys Business Overview
11.16.3 Biognosys Biomarker Discovery Platform Introduction
11.16.4 Biognosys Revenue in Biomarker Discovery Platform Business (2020-2025)
11.16.5 Biognosys Recent Development
11.17 Scailyte
11.17.1 Scailyte Company Details
11.17.2 Scailyte Business Overview
11.17.3 Scailyte Biomarker Discovery Platform Introduction
11.17.4 Scailyte Revenue in Biomarker Discovery Platform Business (2020-2025)
11.17.5 Scailyte Recent Development
11.18 Sapient
11.18.1 Sapient Company Details
11.18.2 Sapient Business Overview
11.18.3 Sapient Biomarker Discovery Platform Introduction
11.18.4 Sapient Revenue in Biomarker Discovery Platform Business (2020-2025)
11.18.5 Sapient Recent Development
11.19 IQVIA Laboratories
11.19.1 IQVIA Laboratories Company Details
11.19.2 IQVIA Laboratories Business Overview
11.19.3 IQVIA Laboratories Biomarker Discovery Platform Introduction
11.19.4 IQVIA Laboratories Revenue in Biomarker Discovery Platform Business (2020-2025)
11.19.5 IQVIA Laboratories Recent Development
11.20 Shanghai InnoStar Bio-tech
11.20.1 Shanghai InnoStar Bio-tech Company Details
11.20.2 Shanghai InnoStar Bio-tech Business Overview
11.20.3 Shanghai InnoStar Bio-tech Biomarker Discovery Platform Introduction
11.20.4 Shanghai InnoStar Bio-tech Revenue in Biomarker Discovery Platform Business (2020-2025)
11.20.5 Shanghai InnoStar Bio-tech Recent Development
11.21 Fapon Biopharma
11.21.1 Fapon Biopharma Company Details
11.21.2 Fapon Biopharma Business Overview
11.21.3 Fapon Biopharma Biomarker Discovery Platform Introduction
11.21.4 Fapon Biopharma Revenue in Biomarker Discovery Platform Business (2020-2025)
11.21.5 Fapon Biopharma Recent Development
11.22 Cobio
11.22.1 Cobio Company Details
11.22.2 Cobio Business Overview
11.22.3 Cobio Biomarker Discovery Platform Introduction
11.22.4 Cobio Revenue in Biomarker Discovery Platform Business (2020-2025)
11.22.5 Cobio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Synexa Life Sciences
Exosome Diagnostics
ALS
Sapient Bioanalytics
Oncimmune Holdings
Evotec
Wuxi Apptec
Baker Heart and Diabetes Institute
BostonGene
Olink
Proteomics International
Excelra
Oncimmune
Broad Clinical Labs
Genialis
Biognosys
Scailyte
Sapient
IQVIA Laboratories
Shanghai InnoStar Bio-tech
Fapon Biopharma
Cobio
听
听
*If Applicable.
